1. A new efficacy parameter (complete/near complete symptom relief) in allergic rhinitis management: results with a new therapy MP29‐02*. (16th July 2013) Authors: Bousquet, Jean; Scadding, Glenis; Price, David; Hellings, Peter; Fokkens, Wytske; Munzel, Ullrich; Bachert, Claus Journal: Clinical and translational allergy Issue: Volume 3(2013)supplement 2 Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A new therapy (MP29‐02*) effectively controls nasal symptoms of seasonal allergic rhinitis irrespective of severity. (16th July 2013) Authors: Scadding, Glenis; Price, David; Bousquet, Jean; Hellings, Peter; Fokkens, Wytske; Munzel, Ullrich; Bachert, Claus Journal: Clinical and translational allergy Issue: Volume 3(2013)supplement 2 Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A new therapy (MP29‐02*) effectively targets the entire seasonal allergic rhinitis symptom complex. (16th July 2013) Authors: Price, David; Bousquet, Jean; Bachert, Claus; Fokkens, Wytske; Scadding, Glenis; Munzel, Ullrich; Hellings, Peter Journal: Clinical and translational allergy Issue: Volume 3(2013)supplement 2 Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. A new therapy (MP29‐02*) effectively treats patients with seasonal allergic rhinitis who suffer most from the bothersome nasal symptom of congestion. (16th July 2013) Authors: Bachert, Claus; Price, David; Scadding, Glenis; Fokkens, Wytske; Hellings, Peter; Munzel, Ullrich; Bousquet, Jean Journal: Clinical and translational allergy Issue: Volume 3(2013)supplement 2 Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. A new therapy (MP29‐02*) provides effective relief from all individual nasal and ocular symptoms of seasonal allergic rhinitis. (16th July 2013) Authors: Hellings, Peter; Bachert, Claus; Bousquet, Jean; Scadding, Glenis; Fokkens, Wytske; Munzel, Ullrich; Price, David Journal: Clinical and translational allergy Issue: Volume 3(2013)supplement 2 Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Assessment of disease control in allergic rhinitis. Issue 1 (18th February 2013) Authors: Demoly, Pascal; Calderon, Moises A; Casale, Thomas; Scadding, Glenis; Annesi‐Maesano, Isabella; Braun, Jean‐Jacques; Delaisi, Bertrand; Haddad, Thierry; Malard, Olivier; Trébuchon, Florence; Serrano, Elie Journal: Clinical and translational allergy Issue: Volume 3:Issue 1(2013) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Short and long‐term safety of MP29‐02*: a new therapy for the treatment of allergic rhinitis. (16th July 2013) Authors: Price, David; Bousquet, Jean; Hellings, Peter; Scadding, Glenis; Fokkens, Wytske; Munzel, Ullrich; Bachert, Claus Journal: Clinical and translational allergy Issue: Volume 3(2013)supplement 2 Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗